Evolus, Inc.

• Evolus, Inc. Estimates – SWB:EVL
  TradingView · 23 Oct 2026
• Bronstein, Gewirtz & Grossman, LLC Encourages Evolus, Inc. (EOLS)
  The National Law Review · 22 Oct 2026
• Evolus to Report Third Quarter Financial Results on November 4, 2026
  BioSpace · 22 Oct 2026
• Press Release: Evolus to Report Third Quarter Financial Results on November 4, 2026
  Moomoo · 21 Oct 2026
• EOLS Q2 2026 Earnings: Evolus Swings to $0.02 EPS, Beating Estimates by 156.8% - New Analyst Coverage
  https://www.siam.in/ · 15 Oct 2026
• Evolus Enters Hair Restoration Market With Potential First-in-class Injectable
  The Dermatology Digest · 15 Oct 2026
• Evolus enters option deal for hair restoration treatment By Investing.com
  Investing.com South Africa · 14 Oct 2026
• Evolus Expands Into Injectable Hair Restoration
  Orange County Business Journal · 14 Oct 2026
• Evolus enters option deal for hair restoration treatment By Investing.com
  Investing.com Nigeria · 14 Oct 2026
• FDA dings Evolus for blurring the lines between Botox rival and lipstick
  Fierce Pharma · 05 Oct 2026
• FDA flags Evolus' Jeuveau Instagram reel for blurring the line between Rx injectable and beauty bag
  Medical Marketing and Media · 05 Oct 2026
• Evolus Warned Over Misbranding in Social Media Promo for Frown Lines Drug - Evolus (NASDAQ:EOLS)
  Benzinga · 02 Oct 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →